CGS-CIMB Research

CGS-CIMB downgrades iFAST Corp on first quarterly profit dip since 1Q19 - THE EDGE SINGAPORE

Broker's Calls

CGS-CIMB downgrades iFast Corp on first quarterly profit dip since 1Q19

Nevertheless, CGS-CIMB Research is raising iFAST’s target price to $8.31 from $8.00 previously.
With strong cash balance, 'add' SIA Engineering for eventual recovery: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

With strong cash balance, 'add' SIA Engineering for eventual recovery: CGS-CIMB

SIA Engineering’s 1QFY3/2022 revenue of $125.3 million, up 9% q-o-q and up 6% y-o-y, was driven by higher flight activities.
Analysts lift ARA LOGOS Logistics Trust's TP to at least 95 cents on continued transformation - THE EDGE SINGAPORE

Broker's Calls

Analysts lift ARA LOGOS Logistics Trust's TP to at least 95 cents on continued transformation

The REIT's results for the 1HFY2021 stood largely in line with analysts' estimates.

Broker's Calls

Analysts stay positive on Suntec REIT as 1HFY21 DPU meets expectations

UOB Kay Hian raised its target price for Suntec REIT to $1.78.
CGS-CIMB keeps 'add' on SATS on its benefitting from the reopening of Changi in FY2022 - THE EDGE SINGAPORE

Broker's Calls

Analysts remain positive on SATS on its benefitting from the reopening of Changi in FY2022 and improving operating stats

SATS' 1QFY2022 earnings of $6.4 million surpassed CGS-CIMB's earnings estimates of $4.4 million.
CGS-CIMB sees 'brighter prospects' for SPH REIT, while Maybank Kim Eng sees the REIT’s recovery as 'slow' - THE EDGE SINGAPORE

Broker's Calls

CGS-CIMB sees 'brighter prospects' for SPH REIT, while Maybank Kim Eng sees the REIT’s recovery as 'slow'

CGS-CIMB has kept 'add' on SPH REIT while Maybank Kim Eng has maintained 'hold'.
Analysts up target prices for Parkway Life REIT following renewal of Singapore hospitals' master lease - THE EDGE SINGAPORE

Broker's Calls

Analysts up target prices for Parkway Life REIT following renewal of Singapore hospitals' master lease

DBS and CGS-CIMB have raised their TPs to $5.75 and $5.05 respectively.
Analysts mixed on UG Healthcare following halt in glove production due to EMCO - THE EDGE SINGAPORE

Broker's Calls

Analysts mixed on UG Healthcare following halt in glove production due to EMCO

RHB and CGS-CIMB have retained their respective 'neutral' and 'add' ratings for UG Healthcare.
Silverlake Axis stands to benefit from return of tech investment appetite: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

Silverlake Axis stands to benefit from return of tech investment appetite: CGS-CIMB

CGS-CIMB has upped the counter’s target price to 35 cents.
×